Skip to main content

Ezetimibe/simvastatin more favorably influences lipoprotein/apolipoprotein ratios than atorvastatin monotherapy in patients with type 2 diabetes

Publication ,  Journal Article
Guyton, JR; Goldberg, RB; Mazzone, T; Weinstock, RS; Polis, A; Rosenberg, E; Edwards, P; Tershakovec, AM
Published in: CIRCULATION
October 31, 2006

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2006

Volume

114

Issue

18

Start / End Page

797 / 797

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guyton, J. R., Goldberg, R. B., Mazzone, T., Weinstock, R. S., Polis, A., Rosenberg, E., … Tershakovec, A. M. (2006). Ezetimibe/simvastatin more favorably influences lipoprotein/apolipoprotein ratios than atorvastatin monotherapy in patients with type 2 diabetes. CIRCULATION, 114(18), 797–797.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 31, 2006

Volume

114

Issue

18

Start / End Page

797 / 797

Location

Chicago, IL

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology